BioSpace News Archive

Seres Therapeutics, Inc. announced that management will host a conference call and live audio webcast on March 6, 2019 at 8:30 a.m. ET to discuss fourth quarter and full year 2018 results and provide a general business update.

Acerus Pharmaceuticals Corporation announced that it has filed a New Drug Submission for Avanafil with Health Canada.

Clinigen Group plc (AIM:CLIN, ‘Clinigen’), the global pharmaceutical and services company, has partnered with Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR, ‘Eiger’) to launch a worldwide lonafarnib Managed Access Program for patients with Progeria and Progeroid Laminopathies.

Companies to advance Intrexon’s Botticelli™ platform to improve efficiency in cannabis plantlet production

Company Announces Additional Key Primary and Secondary Endpoints Further Supporting Vicinium® Treatment Potential in High-Risk Non-Muscle Invasive Bladder Cancer

DLH Holdings Corp. reminded investors that it will hold its upcoming annual meeting of shareholders on March 21, 2019.

New data from Blue Cross Blue Shield, The Health of America Report® (HOA) points to a troubling trend among millennials with major depression.

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade biopreservation media for cell and gene therapies, (“BioLife” or the “Company”), today announced that the Company’s fourth quarter and full year 2018 financial results will be released after market close on Thursday, March 14, 2019,

Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) (“LDS” or the “Company”) is proud to announce that on Thursday, February 28, 2019, the Company’s affiliate, Highway 395 Dispensary, filed plans with the Planning Department of the City of Adelanto for the construction of a freestanding structure for dispensary and delivery operations.

Selvita (WSE: SLV), a clinical stage drug discovery and development company engaged in the research and development of novel cancer therapies, today announced that data from multiple Selvita oncology programs will be presented at the American Association for Cancer Research (AACR) Annual Meeting